Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87


Keratinocyte-associated B7-H1 directly regulates cutaneous effector CD8+ T cell responses.

Ritprajak P, Hashiguchi M, Tsushima F, Chalermsarp N, Azuma M.

J Immunol. 2010 May 1;184(9):4918-25. doi: 10.4049/jimmunol.0902478.


PD-L1 regulates the development, maintenance, and function of induced regulatory T cells.

Francisco LM, Salinas VH, Brown KE, Vanguri VK, Freeman GJ, Kuchroo VK, Sharpe AH.

J Exp Med. 2009 Dec 21;206(13):3015-29. doi: 10.1084/jem.20090847.


Is the prevalence of asthma declining? Systematic review of epidemiological studies.

Anandan C, Nurmatov U, van Schayck OC, Sheikh A.

Allergy. 2010 Feb;65(2):152-67. doi: 10.1111/j.1398-9995.2009.02244.x. Review.


Programmed Death-1 antibody blocks therapeutic effects of T-regulatory cells in cockroach antigen-induced allergic asthma.

McGee HS, Yagita H, Shao Z, Agrawal DK.

Am J Respir Cell Mol Biol. 2010 Oct;43(4):432-42. doi: 10.1165/rcmb.2009-0258OC.


Regulatory T cells in asthma.

Lloyd CM, Hawrylowicz CM.

Immunity. 2009 Sep 18;31(3):438-49. doi: 10.1016/j.immuni.2009.08.007. Review.


PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.

Akbari O, Stock P, Singh AK, Lombardi V, Lee WL, Freeman GJ, Sharpe AH, Umetsu DT, Dekruyff RH.

Mucosal Immunol. 2010 Jan;3(1):81-91. doi: 10.1038/mi.2009.112.


An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation.

Kool M, van Nimwegen M, Willart MA, Muskens F, Boon L, Smit JJ, Coyle A, Clausen BE, Hoogsteden HC, Lambrecht BN, Hammad H.

J Immunol. 2009 Jul 15;183(2):1074-82. doi: 10.4049/jimmunol.0900471.


Fms-like tyrosine kinase 3 ligand increases a lung DC subset with regulatory properties in allergic airway inflammation.

Shao Z, Bharadwaj AS, McGee HS, Makinde TO, Agrawal DK.

J Allergy Clin Immunol. 2009 Apr;123(4):917-924.e2. doi: 10.1016/j.jaci.2009.01.052.


PD-1/PD-L blockade prevents anergy induction and enhances the anti-tumor activities of glycolipid-activated invariant NKT cells.

Parekh VV, Lalani S, Kim S, Halder R, Azuma M, Yagita H, Kumar V, Wu L, Kaer LV.

J Immunol. 2009 Mar 1;182(5):2816-26. doi: 10.4049/jimmunol.0803648.


The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands.

Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, Fauci AS.

J Immunol. 2008 Nov 15;181(10):6738-46.


PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.

Schreiner B, Bailey SL, Shin T, Chen L, Miller SD.

Eur J Immunol. 2008 Oct;38(10):2706-17. doi: 10.1002/eji.200838137.


The development of allergic inflammation.

Galli SJ, Tsai M, Piliponsky AM.

Nature. 2008 Jul 24;454(7203):445-54. doi: 10.1038/nature07204. Review.


Programmed death 1 ligand signaling regulates the generation of adaptive Foxp3+CD4+ regulatory T cells.

Wang L, Pino-Lagos K, de Vries VC, Guleria I, Sayegh MH, Noelle RJ.

Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9331-6. doi: 10.1073/pnas.0710441105.


Dendritic cell programming by cytomegalovirus stunts naive T cell responses via the PD-L1/PD-1 pathway.

Benedict CA, Loewendorf A, Garcia Z, Blazar BR, Janssen EM.

J Immunol. 2008 Apr 1;180(7):4836-47.


PD-1 and its ligands in tolerance and immunity.

Keir ME, Butte MJ, Freeman GJ, Sharpe AH.

Annu Rev Immunol. 2008;26:677-704. doi: 10.1146/annurev.immunol.26.021607.090331. Review.


Programmed death 1 ligand (PD-L) 1 and PD-L2 limit autoimmune kidney disease: distinct roles.

Menke J, Lucas JA, Zeller GC, Keir ME, Huang XR, Tsuboi N, Mayadas TN, Lan HY, Sharpe AH, Kelley VR.

J Immunol. 2007 Dec 1;179(11):7466-77.


B7-DC induced by IL-13 works as a feedback regulator in the effector phase of allergic asthma.

Matsumoto K, Fukuyama S, Eguchi-Tsuda M, Nakano T, Matsumoto T, Matsumura M, Moriwaki A, Kan-o K, Wada Y, Yagita H, Shin T, Pardoll DM, Patcharee R, Azuma M, Nakanishi Y, Inoue H.

Biochem Biophys Res Commun. 2008 Jan 4;365(1):170-5.


Allergic airways disease develops after an increase in allergen capture and processing in the airway mucosa.

von Garnier C, Wikstrom ME, Zosky G, Turner DJ, Sly PD, Smith M, Thomas JA, Judd SR, Strickland DH, Holt PG, Stumbles PA.

J Immunol. 2007 Nov 1;179(9):5748-59.


Dendritic cells in allergic airway inflammation.

Bharadwaj AS, Bewtra AK, Agrawal DK.

Can J Physiol Pharmacol. 2007 Jul;85(7):686-99. Review.

Items per page

Supplemental Content

Support Center